DIEGO
RINCÓN RODRÍGUEZ
Profesor asociado
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (6)
2024
-
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Hepatology
-
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Journal of Hepatology, Vol. 81, Núm. 1, pp. 76-83
2020
-
Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort
Journal of Hepatology, Vol. 72, Núm. 4, pp. 702-710
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2017
-
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
The Lancet Infectious Diseases, Vol. 17, Núm. 10, pp. 1062-1068
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498